ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has entered through its Polish subsidiary into a collaboration...
Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
ODI Pharma AB receives loan financing of EUR 350,000
ODI Pharma receives approval from the Office for Registration of Medicinal Products in Poland
Correction: ODI Pharma AB: Publication of half-year report 2021
ODI Pharma AB: Publication of half-year report 2021
ODI Pharma AB: Flagging notification
ODI Pharma: Update on progress in “Project Poland” and “Project Skin”
ODI Pharma achieves milestone towards market entry in Poland
ODI Pharma proceeds with its plans and launches Project Skin
ODI PHARMA AB AND APHRIA INC. EXECUTE SUPPLY AGREEMENT
ODI Pharma AB: Publication of year-end report
ODI Pharma AB: Status update in connection to COVID-19
ODI Pharma AB: Publication of half-yearly report 2019
First registration of ODI Pharma’s new share issue completed
ODI Pharma’s new share issue prior to listing significantly oversubscribed
ODI Pharma has been approved for listing on Spotlight Stock Market, subscription period starts today